Chemists Discuss Homeland Defense

While the anthrax letters of October 2001 sent microbiologists and geneticists into an unwanted limelight, the chemical community also found itself suddenly grappling with how their field fits into the post-9/11 world. The news from a Jan. 14-16 meeting at the Arnold and Mabel Beckman Center of the National Academies of Science and Engineering in Irvine, California, "National Security and Homeland Defense," was upbeat. The goal of the meeting, the third in a series called Challenges for the Chem

Written byRicki Lewis
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The goal of the meeting, the third in a series called Challenges for the Chemical Sciences in the 21st Century, was to identify and forge connections between what chemists can do to promote homeland security and what the government must do to understand and apply that help. The 110 invited participants, representing academia and industry, heard 10 speakers and shared ideas in several breakout sessions. One session pinpointed areas likely to have direct impact on national security and defense: analytical chemistry, high throughput analysis, PCR, electronic materials and processes, and drug discovery and development.

David Franz, vice president of the chemical and biological defense division of the Southern Research Institute in Frederick, Md., kicked off the meeting with a brief history of bioweaponry. He then outlined the obstacles that a bioterrorism attack must overcome to actually succeed on a large scale. Although dependence on precise meteorological conditions is a limiting ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies